Helsingborg, Sweden

Lars J Stalhandske


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1985-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lars J Stalhandske

Introduction

Lars J Stalhandske is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance immune system activity. With a total of 2 patents to his name, Stalhandske's work is recognized for its potential impact on medical treatments.

Latest Patents

Stalhandske's latest patents include "N-aryl-1,2-dihydro-4-substituted-1-alkyl-2-oxo-quinoline-3-carboxamides." This invention relates to novel heterocyclic carboxamides that increase the activity of the immune system and outlines methods for their preparation. Additionally, he has developed pharmaceutical compositions containing these compounds and methods of treatment utilizing them. His focus on heterocyclic carboxamides showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Lars J Stalhandske has worked with prominent companies such as Aktiebolaget Leo. His experience in these organizations has contributed to his expertise in pharmaceutical innovations. Stalhandske's work has been instrumental in the development of new therapeutic approaches.

Collaborations

Stalhandske has collaborated with various professionals in his field, including Edgar Eriksoo and Eva B Sandberg. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Lars J Stalhandske's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments that enhance immune system activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…